BSE filing, NSE: BORANA. Summary written from the filing by ALFA Finder's alert engine.
Borana Weaves Ltd: key numbers
- Share price
- ₹206.20
- Market cap
- ₹549.4 Cr
- Revenue (annual)
- ₹388.6 Cr
- Net profit (annual)
- ₹64.61 Cr
- P/E (TTM)
- 8.0×Sector 50.0×
- Promoter holding
- 65.24%+0.00% QoQ
- FII holding
- 1.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Borana Weaves Ltd
All →Borana Weaves Board Meeting Date
Borana Weaves scheduled a board meeting for 02 Nov 2026 to consider results and adding 192 looms at Unit 4. Items are proposed, not yet approved.
- water jet loom capacity
- 192 looms
Borana Weaves Other Announcement
Borana Weaves Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Borana Weaves Business Update
Borana Weaves Ltd announced a further delay in commissioning its 9.9 MW Hybrid Power Project due to adverse weather and logistical challenges.
- hybrid power project capacity
- 9.9 MW
Borana Weaves Other Announcement
Borana Weaves Ltd's shareholders approved the re-appointment of M/s. KSA & Co. as the company's statutory auditor for a five-year term at the Annual General Meeting.
Borana Weaves Annual General Meeting
Borana Weaves Limited held its 6th Annual General Meeting on September 29, 2026. Shareholders considered eight agenda items including adoption of financial statements and auditor appointments.
Borana Weaves Debt & Borrowing: ₹5 Cr
Borana Weaves Limited has entered into an agreement to provide an unsecured loan of up to ₹5 Crore to Win Star Industries Private Limited.
- Value
- ₹5.00 Cr
Other regulatory approval announcements
All →Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.